You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Sale Disclosure
Pearce Samantha · SEC Form 4 · Filed Jun 1, 2026
Sale
Calculated transaction value
$1.63M
Pearce Samantha EVP, Chief Commercial Officer
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
May 28, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 4 days later
JAZZ daily price context
Close on/before transaction
$235.38
May 28, 2026
First close after public filing
$226.12
Jun 2, 2026
30-day return after filing
+5.04%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 6,907 shares @ $235.41
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001805688-26-000008
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.38M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ | Exercise | May 28, 2026 | $755.97K |
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | May 28, 2026 | $1.63M |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | May 28, 2026 | $0 |